Clinical Trial End Points for Hemodialysis Vascular Access: Background, Rationale, and Definitions.
作者信息
Shenoy Surendra, Allon Michael, Beathard Gerald, Brouwer-Maier Deborah, Dember Laura M, Glickman Mark, Lee Celeste, Litchfield Terry, Lok Charmaine, Huber Thomas, Roy-Chaudhury Prabir, Work Jack, West Melissa, Wasse Haimanot
机构信息
Due to the number of contributing authors, the affiliations are provided in the Supplemental Material .
出版信息
Clin J Am Soc Nephrol. 2018 Mar 7;13(3):490-494. doi: 10.2215/CJN.13321216. Epub 2018 Feb 27.
Abstract
摘要
相似文献
1
Clinical Trial End Points for Hemodialysis Vascular Access: Background, Rationale, and Definitions.
Clin J Am Soc Nephrol. 2018 Mar 7;13(3):490-494. doi: 10.2215/CJN.13321216. Epub 2018 Feb 27.
2
FDA Regulatory Perspectives for Studies on Hemodialysis Vascular Access.
Clin J Am Soc Nephrol. 2018 Mar 7;13(3):513-518. doi: 10.2215/CJN.02900317. Epub 2017 Jul 24.
3
Definitions and End Points for Interventional Studies for Arteriovenous Dialysis Access.
Clin J Am Soc Nephrol. 2018 Mar 7;13(3):501-512. doi: 10.2215/CJN.11531116. Epub 2017 Jul 20.
4
Vascular Access Type and Clinical Outcomes among Elderly Patients on Hemodialysis.
Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1823-1830. doi: 10.2215/CJN.01410217. Epub 2017 Aug 10.
5
Hemodialysis access in the pediatric patient population.
Am J Surg. 1994 Aug;168(2):197-201. doi: 10.1016/s0002-9610(94)80067-7.
6
Vascular Access: Inukshuk.
Adv Chronic Kidney Dis. 2015 Nov;22(6):413-7. doi: 10.1053/j.ackd.2015.09.002.
7
Stent-graft arteriovenous fistula: an endovascular technique in hemodialysis access.
J Endovasc Surg. 1998 Feb;5(1):18-23. doi: 10.1583/1074-6218(1998)005<0018:SGAFAE>2.0.CO;2.
8
Synthetic vascular hemodialysis access versus native arteriovenous fistula: a cost-utility analysis.
Ann Surg. 2012 Jan;255(1):181-6. doi: 10.1097/SLA.0b013e31822f4e9b.
9
Current strategies for vascular access in patients on hemodialysis.
ASAIO J. 1992 Oct-Dec;38(4):743-4.
10
Vascular access in hemodialysis: issues, management, and emerging concepts.
Cardiol Clin. 2005 Aug;23(3):249-73. doi: 10.1016/j.ccl.2005.04.004.
引用本文的文献
1
Predicting long-term patency of radiocephalic arteriovenous fistulas with machine learning and the PREDICT-AVF web app.
Sci Rep. 2025 Jun 1;15(1):19203. doi: 10.1038/s41598-025-04310-y.
2
Long-term outcomes of refractory central venous occlusive disease treated by stent deployment in patients undergoing maintenance hemodialysis.
Ren Fail. 2025 Dec;47(1):2463579. doi: 10.1080/0886022X.2025.2463579. Epub 2025 Feb 16.
3
Outcomes of Endovascular Treatment for Salvaging Failed Hemodialysis Arteriovenous Fistula - Role of Balloon Angioplasty as Initial Therapy.
Indian J Nephrol. 2024 Nov-Dec;34(6):583-588. doi: 10.25259/ijn_539_23. Epub 2024 Jun 24.
4
Outcomes Following Arteriovenous Fistula Creation in Medicare Beneficiaries With End-Stage Kidney Disease.
Am J Cardiol. 2025 Jan 1;234:79-86. doi: 10.1016/j.amjcard.2024.10.006. Epub 2024 Oct 22.
5
Evaluating the effectiveness of systemic heparin during arteriovenous fistula creation by emulating a target trial.
Am J Epidemiol. 2025 Mar 4;194(3):651-658. doi: 10.1093/aje/kwae098.
6
Evaluating national guideline concordance of recurrent interventions after radiocephalic arteriovenous fistula creation.
J Vasc Surg. 2023 Apr;77(4):1206-1215.e2. doi: 10.1016/j.jvs.2022.12.017. Epub 2022 Dec 22.
7
Angioplasty of Dysfunctional Dialysis Fistula or Graft with Resveratrol-Excipient and Paclitaxel-Coated Balloon Improves Primary Patency Rates Compared to Plain Angioplasty Alone.
J Clin Med. 2022 Dec 14;11(24):7405. doi: 10.3390/jcm11247405.
8
The Effects of Vasodilation Induced by Brachial Plexus Block on the Development of Postoperative Thrombosis of the Arteriovenous Access in Patients with End-Stage Renal Disease: A Retrospective Study.
Int J Environ Res Public Health. 2022 Nov 17;19(22):15158. doi: 10.3390/ijerph192215158.
9
Study protocol for Vascular Access outcome measure for function: a vaLidation study In hemoDialysis (VALID) : A multi-center, multinational validation study to assess the accuracy and feasibility of measuring vascular access function in clinical practice.
BMC Nephrol. 2022 Nov 19;23(1):372. doi: 10.1186/s12882-022-02987-1.
10
Radiocephalic Arteriovenous Fistula Patency and Use: A Post Hoc Analysis of Multicenter Randomized Clinical Trials.
Ann Surg Open. 2022 Aug 23;3(3):e199. doi: 10.1097/AS9.0000000000000199. eCollection 2022 Sep.
本文引用的文献
1
FDA Regulatory Perspectives for Studies on Hemodialysis Vascular Access.
Clin J Am Soc Nephrol. 2018 Mar 7;13(3):513-518. doi: 10.2215/CJN.02900317. Epub 2017 Jul 24.
2
Definitions and End Points for Interventional Studies for Arteriovenous Dialysis Access.
Clin J Am Soc Nephrol. 2018 Mar 7;13(3):501-512. doi: 10.2215/CJN.11531116. Epub 2017 Jul 20.
3
Recommended Clinical Trial End Points for Dialysis Catheters.
Clin J Am Soc Nephrol. 2018 Mar 7;13(3):495-500. doi: 10.2215/CJN.12011116. Epub 2017 Jul 20.
4
Overcoming Barriers in Kidney Health-Forging a Platform for Innovation.
J Am Soc Nephrol. 2016 Jul;27(7):1902-10. doi: 10.1681/ASN.2015090976. Epub 2016 Apr 28.
5
Fostering innovation, advancing patient safety: the kidney health initiative.
Clin J Am Soc Nephrol. 2013 Sep;8(9):1609-17. doi: 10.2215/CJN.01140113. Epub 2013 Jun 6.
6
Standardized definitions for hemodialysis vascular access.
Semin Dial. 2011 Sep-Oct;24(5):515-24. doi: 10.1111/j.1525-139X.2011.00969.x. Epub 2011 Sep 9.
7
The Society for Vascular Surgery: clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access.
J Vasc Surg. 2008 Nov;48(5 Suppl):2S-25S. doi: 10.1016/j.jvs.2008.08.042.
8
Reporting standards for percutaneous interventions in dialysis access.
J Vasc Interv Radiol. 2003 Sep;14(9 Pt 2):S433-42. doi: 10.1097/01.rvi.0000094618.61428.58.
9
III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000.
Am J Kidney Dis. 2001 Jan;37(1 Suppl 1):S137-81. doi: 10.1016/s0272-6386(01)70007-8.
Zotero 插件